BAM
STSA

Blueshift Asset Management’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Blueshift Asset Management’s Portfolio STSA Stock Details STSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,143
Closed -$39K – 930
2020
Q3 		$39K Buy
+10,143
New +$204K 0.01% 580

Other funds holding STSA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Blueshift Asset Management's STSA Position: Q4 2020 in Review

Blueshift Asset Management sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q4 2020, closing a stake of 10,143 shares — an estimated $39K sold.

Blueshift Asset Management first reported a position in STSA in Q3 2020 and held it in 1 quarter. The position peaked at $39K in Q3 2020. 48 funds tracked by Wall St. Rank hold STSA as of Q4 2020.

  • Blueshift Asset Management reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Blueshift Asset Management sold 10,143 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q4 2020, an estimated $39K.
  • Blueshift Asset Management first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Blueshift Asset Management's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $39K in Q3 2020.
  • 48 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q4 2020.

Based on Blueshift Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.